Metraipolis › archive › dc_f32dada47e65

The influence of concomitant proton pump inhibitors use on treatment efficacy in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a… — Europe PMC PMID:41798943

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41798943
DOI
10.3389/fimmu.2026.1717420
License (as archived)
solo-consultazione
Archived
2026-11-06T03:45:01.456Z
SHA-256 of the archived text
9102aa453e1fe2676d5b6dfc55f5a200ba5974020a7b1e0ead020358daee64cd
Stable URL of this page
https://metraipolis.com/documento/dc_f32dada47e65

How to cite

The influence of concomitant proton pump inhibitors use on treatment efficacy in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a… — Europe PMC PMID:41798943 — Europe PMC (en), https://europepmc.org/article/MED/41798943 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f32dada47e65 (Metraipolis archive dc_f32dada47e65, sha256 9102aa453e1fe2676d5b6dfc55f5a200ba5974020a7b1e0ead020358daee64cd)
BibTeX
@misc{dcf32dada47e65,
  title = {The influence of concomitant proton pump inhibitors use on treatment efficacy in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a… — Europe PMC PMID:41798943},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41798943},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f32dada47e65; sha256 9102aa453e1fe2676d5b6dfc55f5a200ba5974020a7b1e0ead020358daee64cd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798943. Agents can read the archived copy with the MCP tool read_document.